Inventor · disambiguated record
Benjamin Mugrage
Also filed as: MUGRAGE BENJAMIN · MUGRAGE BENJAMIN B · MUGRAGE BENJAMIN BIRO
21 granted patents·5 pending applications·334 citations·filing 1991–2017
95Inventor score
Top patents by PatentIndex Score
26 records- 0194US6291523B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·117 cites·36 claims
- 0293US6310099B1Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2000·Granted Oct 30, 2001·54 cites·19 claims
- 0391US9273031B2Combination therapy with MDM2 and EFGR inhibitorsERRICO JOSEPH P·Filed 2014·Granted Mar 1, 2016·12 cites·14 claims
- 0490US9181184B2Method for the treatment of pompe disease using 1-deoxynojirimycin and derivativesMUGRAGE BENJAMIN·Filed 2006·Granted Nov 10, 2015·28 cites·4 claims
- 0590US7501439B2Tartrate salt of isofagomine and methods of useAMICUS THERAPEUTICS INC·Filed 2007·Granted Mar 10, 2009·14 cites·9 claims
- 0690US6174888B12-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Jan 16, 2001·48 cites·9 claims
- 0784US6727281B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2002·Granted Apr 27, 2004·13 cites·17 claims
- 0883US8658170B2Combination therapy with MDM2 and EFGR inhibitorsERRICO JOSEPH P·Filed 2011·Granted Feb 25, 2014·7 cites·13 claims
- 0981US6451858B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2001·Granted Sep 17, 2002·10 cites·10 claims
- 1075US8618302B2Methods and compositions of targeted drug developmentERRICO JOSEPH P·Filed 2011·Granted Dec 31, 2013·3 cites·26 claims
- 1175US7115662B2Certain 5-alkyl-2-arylaminophenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Oct 3, 2006·5 cites·18 claims
- 1274US7863453B2Tartrate salt of isofagomine and methods of useAMICUS THERAPEUTICS INC·Filed 2009·Granted Jan 4, 2011·1 cites·34 claims
- 1371US7202364B2Certain phenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Apr 10, 2007·7 cites·10 claims
- 1467US11602528B2Method for the treatment of Pompe disease using 1-deoxynojirimycin derivativesAMICUS THERAPEUTICS INC·Filed 2017·Granted Mar 14, 2023·0 cites·10 claims
- 1566US5180718AAcyl derivatives of oxazolorifamycinsCIBA GEIGY CORP·Filed 1991·Granted Jan 19, 1993·11 cites·33 claims
- 1661US9023354B2Combination therapy with MDM2 and EFGR inhibitorsERRICO JOSEPH P·Filed 2014·Granted May 5, 2015·0 cites·8 claims
- 1761US8362294B2Phenylacetic acid derivativesNOVARTIS AG·Filed 2007·Granted Jan 29, 2013·0 cites·2 claims
- 1860US2010197018A1Use of substrates as pharmacological chaperonesAMICUS THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1955US9073858B2Methods of targeted drug developmentERRICO JOSEPH P·Filed 2013·Granted Jul 7, 2015·0 cites·20 claims
- 2052US2014179681A1Methods and compositions of targeted drug developmentERRICO JOSEPH P·Filed 2014·Application pending·0 cites
- 2150US8586782B2Phenylacetic acid derivativesMONOVICH LAUREN G·Filed 2012·Granted Nov 19, 2013·0 cites·1 claims
- 2249US2014058129A1Phenylacetic Acid DerivativesMONOVICH LAUREN G·Filed 2013·Application pending·0 cites
- 2347US2016051528A1Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin DerivativesAMICUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2446US2008015194A1Methods and compositions of targeted drug developmentERRICO JOSEPH P·Filed 2007·Application pending·0 cites
- 2541US6043365APreparation of 2-amino-7-(1-substituted-2-hydroxyethyl)-3, 5-dihydropyrrolo[3,2-d]pyrimidin-4-onesNOVARTIS AG·Filed 1998·Granted Mar 28, 2000·4 cites·14 claims
- 2633US5576439ADihydropyridinecarboxylic acid anhydridesCIBA GEIGY CORP·Filed 1994·Granted Nov 19, 1996·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Benjamin Mugrage files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →